| Dr Peter D Vizzi, MD | |
|
1301 Camellia Blvd, Suite 102, Lafayette, LA 70508-7089 | |
| (337) 233-3201 | |
| (337) 233-3207 |
| Full Name | Dr Peter D Vizzi |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 31 Years |
| Location | 1301 Camellia Blvd, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548230048 | NPI | - | NPPES |
| 1462021 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 15373R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Park Place Surgical Hospital | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana Orthopaedic Specialists, Llc | 1850469305 | 63 |
News Archive
Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.
A California nonprofit meant to facilitate health information exchange has closed its doors after losing a bid to become the state's main exchange organization, Modern Healthcare reports. Board members for California Regional Health Information Organization, or CalRHIO, voted to disband after their company failed to win contracts with the state or negotiate a partnership that would fulfill state requirements.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Boys with a large increase in body mass index (BMI) during puberty are at increased risk of death due to cardiovascular disease later in life.
› Verified 5 days ago
| Entity Name | Peter D Vizzi Md Amc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609065812 PECOS PAC ID: 3870578222 Enrollment ID: O20040621001306 |
News Archive
Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.
A California nonprofit meant to facilitate health information exchange has closed its doors after losing a bid to become the state's main exchange organization, Modern Healthcare reports. Board members for California Regional Health Information Organization, or CalRHIO, voted to disband after their company failed to win contracts with the state or negotiate a partnership that would fulfill state requirements.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Boys with a large increase in body mass index (BMI) during puberty are at increased risk of death due to cardiovascular disease later in life.
› Verified 5 days ago
| Entity Name | Louisiana Orthopaedic Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063669612 PECOS PAC ID: 1850469305 Enrollment ID: O20081010000131 |
News Archive
Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.
A California nonprofit meant to facilitate health information exchange has closed its doors after losing a bid to become the state's main exchange organization, Modern Healthcare reports. Board members for California Regional Health Information Organization, or CalRHIO, voted to disband after their company failed to win contracts with the state or negotiate a partnership that would fulfill state requirements.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Boys with a large increase in body mass index (BMI) during puberty are at increased risk of death due to cardiovascular disease later in life.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter D Vizzi, MD 1301 Camellia Blvd, Suite 102, Lafayette, LA 70508-7089 Ph: (337) 233-3201 | Dr Peter D Vizzi, MD 1301 Camellia Blvd, Suite 102, Lafayette, LA 70508-7089 Ph: (337) 233-3201 |
News Archive
Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.
A California nonprofit meant to facilitate health information exchange has closed its doors after losing a bid to become the state's main exchange organization, Modern Healthcare reports. Board members for California Regional Health Information Organization, or CalRHIO, voted to disband after their company failed to win contracts with the state or negotiate a partnership that would fulfill state requirements.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Boys with a large increase in body mass index (BMI) during puberty are at increased risk of death due to cardiovascular disease later in life.
› Verified 5 days ago
Otis Rashad Drew, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4212 W Congress St Ste 3100, Lafayette, LA 70506 Phone: 337-703-3201 Fax: 337-703-3202 | |
David Scott Muldowny, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 102, Lafayette, LA 70508 Phone: 337-234-5234 Fax: 337-235-2121 | |
John Novotny, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4704 Ambassador Caffery Pkwy Fl 1, Lafayette, LA 70508 Phone: 337-470-5920 Fax: 855-431-6868 | |
Dr. James Barrett Kyle, M.D., D.V.M. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 108 Rue Louis Xiv, Lafayette, LA 70508 Phone: 337-235-8007 Fax: 855-270-5479 | |
Dr. J Hugh Larriviere, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2600 Johnston St, Ste 200, Lafayette, LA 70503 Phone: 337-232-1234 | |
Brian Edward Etier Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4212 W Congress St Ste 3100, Lafayette, LA 70506 Phone: 337-703-3201 Fax: 337-703-3202 | |
Dr. Harold J Granger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4809 Ambassador Caffery Pkwy, Suite 200, Lafayette, LA 70508 Phone: 337-988-8855 Fax: 337-988-8833 |